BMS-986122   Click here for help

GtoPdb Ligand ID: 9157

Compound class: Synthetic organic
Comment: BMS-986122 is a positive allosteric modulator (PAM) of the μ opioid receptor [3]. It is one of the compounds claimed in patent WO2014107344 [2]. BMS-986122 is built on a chemical scaffold representing a new chemotype for μ receptor PAMs [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 0
Rotatable bonds 4
Topological polar surface area 80.29
Molecular weight 446.94
XLogP 4.66
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES COc1ccc(cc1Br)C1SCCN1S(=O)(=O)c1ccc(cc1)Cl
Isomeric SMILES COc1ccc(cc1Br)C1SCCN1S(=O)(=O)c1ccc(cc1)Cl
InChI InChI=1S/C16H15BrClNO3S2/c1-22-15-7-2-11(10-14(15)17)16-19(8-9-23-16)24(20,21)13-5-3-12(18)4-6-13/h2-7,10,16H,8-9H2,1H3
Bioactivity Comments
BMS-986122 has little or no agonist activity alone. It dose dependently increases endomorphin-1 induced β-arrestin recruitment and inhibition of forskolin-induced adenyl cyclase activity and also potentiates DAMGO-stimulated GTPγS receptor binding [3].
Selectivity at GPCRs
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
μ receptor Hs Allosteric modulator Positive 5.3 pKB - 3
pKB 5.3 (KB 5x10-6 M) [3]
μ receptor Hs Allosteric modulator Positive 5.5 pEC50 - 3
pEC50 5.5 (EC50 3x10-6 M) [3]